덱스컴 (DXCM) 주가

덱스컴(DXCM)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $89.67 (+1.98%), 시가총액 $27.57B, PER (주가수익비율) 28.69, 52주 최저~최고 $54.84 ~ $89.53.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabet

핵심 지표

• 현재가: $89.67 (+1.98%)
• 시가총액: $27.57B
• PER (주가수익비율): 28.69
• 52주 최저~최고: $54.84 ~ $89.53
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

덱스컴의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

덱스컴 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5385

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 8.74
• 순이익률: 0.19%
• 영업이익률: 0.21%

자주 묻는 질문